Nuvectis Pharma, Inc.
For the period ended Dec 31, 2025. Filed Feb 11, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 11, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
On May 3, 2025, we entered into a one-year lease for office space at 1 Bridge Plaza, 2 nd Floor, Fort Lee, NJ 07024. We have taken possession of this space, which serves as our principal executive offices. Total rent expense over the full term of the lease will be approximately $15,000. We believe that our existing facilities are adequate to meet our current requirements. We plan to extend the lease prior to its expiration on May 3, 2026.
On August 22, 2025, we entered into a three-month lease at 216 East 52nd Street, New York, NY 10022. Total rent expense over the full term was $18,000. The lease has since expired and we did not renew the lease.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.